| $687M | ||
| $385M | ||
| $215M | ||
| $100M | ||
| $87M | ||
| $82M |
Buys | $326,010 | 8 | 100 |
Sells | $0 | 0 | 0 |
| McNamara Robert | director | 4 | $287,200 | 0 | $0 | $287,200 |
| O'Toole David D | CFO | 4 | $38,810 | 0 | $0 | $38,810 |
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
Over the last 12 months, insiders at AVITA Medical, Inc. have bought $326,010 and sold $0 worth of AVITA Medical, Inc. stock.
On average, over the past 5 years, insiders at AVITA Medical, Inc. have bought $158,551 and sold $218,215 worth of stock each year.
Highest buying activity among insiders over the last 12 months: McNamara Robert (director) — $287,200. O'Toole David D (CFO) — $38,810.
The last purchase of 10,000 shares for transaction amount of $45,000 was made by McNamara Robert (director) on 2025‑08‑28.
| 2025-08-28 | McNamara Robert | director | 10,000 0.0386% | $4.50 | $45,000 | -8.90% | ||
| 2025-08-26 | O'Toole David D | CFO | 2,000 0.007% | $4.52 | $9,040 | -12.06% | ||
| 2025-08-19 | McNamara Robert | director | 10,000 0.0385% | $5.00 | $50,000 | -14.89% | ||
| 2025-08-12 | O'Toole David D | CFO | 2,000 0.0076% | $4.81 | $9,620 | -23.73% | ||
| 2025-03-06 | McNamara Robert | director | 11,000 0.0415% | $8.30 | $91,300 | -33.98% | ||
| 2025-02-20 | McNamara Robert | director | 10,000 0.0375% | $10.09 | $100,900 | -44.57% | ||
| 2025-02-20 | O'Toole David D | CFO | 1,000 0.0037% | $9.90 | $9,900 | -44.57% | ||
| 2025-02-19 | O'Toole David D | CFO | 1,000 0.0038% | $10.25 | $10,250 | -45.99% | ||
| 2024-12-09 | Crowe Suzanne | director | 486 0.0018% | $13.15 | $6,391 | -56.68% | ||
| 2024-12-05 | O'Toole David D | CFO | 975 0.0037% | $12.46 | $12,152 | -51.89% | ||
| 2024-05-30 | O'Toole David D | CFO | 1,000 0.0037% | $8.90 | $8,900 | +0.75% | ||
| 2024-02-28 | O'Toole David D | CFO | 1,250 0.005% | $17.39 | $21,738 | -41.55% | ||
| 2023-12-26 | Sale | CORBETT JAMES | CEO | 1,445 0.0057% | $13.29 | $19,204 | -23.39% | |
| 2023-12-21 | Sale | COOK JEREMY CURNOCK | director | 2,500 0.01% | $12.49 | $31,225 | -16.85% | |
| 2023-12-13 | Sale | COOK JEREMY CURNOCK | director | 2,518 0.0095% | $12.27 | $30,896 | -20.24% | |
| 2023-12-12 | O'Toole David D | CFO | 950 0.0039% | $12.45 | $11,828 | -14.71% | ||
| 2023-12-01 | O'Toole David D | CFO | 500 0.0019% | $10.68 | $5,340 | -7.12% | ||
| 2023-11-21 | O'Toole David D | CFO | 2,000 0.008% | $10.28 | $20,560 | +2.90% | ||
| 2023-11-16 | O'Toole David D | CFO | 1,000 0.0038% | $12.15 | $12,150 | -17.17% | ||
| 2023-11-15 | O'Toole David D | CFO | 2,000 0.0078% | $12.85 | $25,700 | -19.20% |
| McNamara Robert | director | 86771 0.3238% | $295,889.11 | 4 | 0 | |
| O'Toole David D | CFO | 31657 0.1181% | $107,950.37 | 17 | 0 | <0.0001% |
| PERRY MICHAEL S | Chief Executive Officer | 321712 1.2006% | $1.1M | 0 | 8 | |
| Shiroma Donna | General Counsel | 42257 0.1577% | $144,096.37 | 0 | 1 | |
| Crowe Suzanne | director | 36912 0.1378% | $125,869.92 | 2 | 0 | <0.0001% |
| COOK JEREMY CURNOCK | director | 20614 0.0769% | $70,293.74 | 0 | 2 | |
| CORBETT JAMES | CEO | 11580 0.0432% | $39,487.80 | 0 | 1 | |
| McIntyre David | Chief Financial Officer | 893 0.0033% | $3,045.13 | 2 | 0 | <0.0001% |
| Increased Positions | 27 | +22.31% | 564,860 | +7.3% |
| Decreased Positions | 54 | -44.63% | 3M | -40.3% |
| New Positions | 14 | New | 293,043 | New |
| Sold Out Positions | 19 | Sold Out | 867,101 | Sold Out |
| Total Postitions | 94 | -22.31% | 5M | -33.01% |
| Vanguard Group Inc | $4,725.00 | 4.55% | 1.37M | -84,890 | -5.85% | 2025-09-30 |
| Blackrock, Inc. | $3,939.00 | 3.8% | 1.14M | -757,219 | -39.95% | 2025-09-30 |
| State Street Corp | $1,465.00 | 1.41% | 423,308 | -105,476 | -19.95% | 2025-09-30 |
| Geode Capital Management, Llc | $1,147.00 | 1.11% | 331,463 | -286,879 | -46.4% | 2025-09-30 |
| Northern Trust Corp | $598.00 | 0.58% | 172,778 | -86,819 | -33.44% | 2025-09-30 |
| Millennium Management Llc | $459.00 | 0.44% | 132,709 | -236,483 | -64.05% | 2025-09-30 |
| Aqr Capital Management Llc | $413.00 | 0.4% | 119,288 | +97,365 | +444.12% | 2025-09-30 |
| Bridgeway Capital Management, Llc | $408.00 | 0.39% | 118,004 | +80,404 | +213.84% | 2025-09-30 |
| Goldman Sachs Group Inc | $404.00 | 0.39% | 116,845 | +23,190 | +24.76% | 2025-09-30 |
| Divisadero Street Capital Management, Lp | $346.00 | 0.33% | 100,000 | +100,000 | New | 2025-09-30 |